Advicenne Aktie
| 1,74EUR | 0,01EUR | 0,58% |
WKN DE: A2H8SU / ISIN: FR0013296746
Personal
| 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| Personal am Ende des Jahres | 0 | 26 | 19 | 20 | 0 |
| Umsatz pro Mitarbeiter in Mio. EUR | 0,00 | 0,10 | 0,12 | 0,15 | 0,00 |
Bilanz (in Mio. EUR) - Aktiva
| 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| Summe Umlaufvermögen | 21 | 17 | 12 | 9 | 0 |
| Summe Anlagevermögen | 3 | 2 | 2 | 3 | 0 |
| Summe Aktiva | 24 | 19 | 14 | 12 | 0 |
Bilanz (in Mio. EUR) - Passiva
| 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| Summe Fremdkapital | 21 | 19 | 25 | 24 | 0 |
| Summe Eigenkapital | 3 | 0 | -11 | -12 | 0 |
| Summe Passiva | 24 | 19 | 14 | 12 | 0 |
Adresse
| 262 Rue du Faubourg Saint Honoré, 75008 Paris | |
| Telefon | +33 (4) 66-05-54-20 |
| Fax | +33 (4) 66-21-23-35 |
| Internet | http://advicenne.com |
Management
|
André Ulmann
Director |
|
Catherine Dunand
Independent Director |
|
Catherine Guittet
Head-Clinical Operations Department |
|
Charlotte E. Sibley
Independent Director |
|
Didier Laurens
Chief Executive Officer, CFO & Director |
|
Hege Hellstrom
Chief Commercial Officer |
|
Laurent Cassedannemr
Chief Pharmaceutical Officer & Quality Director |
|
Nathalie Lemarié
Director-Regulatory Affairs |
|
Philippe Boucheron
Chairman |
|
Renaud du Lac
Director |
|
Thibaut Roulon
Independent Director |
|
Véronique Leblanc
Medical Director-EMEA |
ETF-Sparplan
Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.